StonvexLoading…
StonvexStonvexStonvexCore line items from DNLI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $-555.34M | $-487.34M | $-357.50M | $-234.31M |
Net Income | $-512.54M | $-422.77M | $-308.02M | $-200.83M |
EPS (Diluted) | $-2.97 | $-2.57 | $-1.89 | $-1.26 |
Total Assets | $1.14B | $1.37B | $1.45B | $1.50B |
Total Liabilities | $131.09M | $144.50M | $135.52M | $115.51M |
Cash & Equivalents | $205.33M | $174.96M | $90.64M | $74.68M |
Free Cash Flow OCF − CapEx | $-422.10M | $-363.61M | $-274.80M | $-211.78M |
Shares Outstanding | 156.18M | 144.22M | 143.84M | 143.12M |